v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2025
Oct. 31, 2024
Operating activities:    
Net income (loss) $ 33,657 $ (20,673)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 20,304 12,101
Impairment of long-lived assets 3,807 0
Bad debt expense 2,033 1,017
Stock-based compensation expense 37,959 37,091
Amortization of operating lease right-of-use assets 7,063 6,471
Adjustments to contingent consideration (25,900) 607
Other, net 663 (751)
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:    
Accounts receivable 49,817 55,285
Prepaid expenses and other current assets (1,822) (74)
Costs to obtain revenue contracts 9,249 10,476
Other long term assets 6,502 256
Accounts payable, accrued expenses and other current liabilities (17,480) 7,181
Unearned revenue (77,384) (89,117)
Operating lease liabilities (10,604) (8,312)
Other long term liabilities (11,552) 307
Net cash provided by operating activities 26,312 11,865
Investing activities:    
Capital expenditures (1,650) (1,769)
Cash paid in acquisitions, net of cash acquired (18,801) (89,407)
Net cash used in investing activities (20,451) (91,176)
Financing activities:    
Proceeds from exercise of stock options 1,773 1,137
Proceeds from debt issuance 99,000 0
Repurchase of common stock (59,776) (6,760)
Payments for taxes related to net share settlement of stock-based compensation awards (18,473) (9,031)
Payments of deferred financing costs (1,045) (777)
Deferred acquisition payments (13,509) 0
Proceeds, net from employee stock purchase plan withholdings 2,099 2,218
Net cash provided by (used in) financing activities 10,069 (13,213)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 4,347 345
Net increase (decrease) in cash, cash equivalents and restricted cash 20,277 (92,179)
Cash, cash equivalents and restricted cash at beginning of period 138,654 210,184
Cash, cash equivalents and restricted cash at end of period $ 158,931 $ 118,005

Source

HTML PDF
ZIP